Business

Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc.

Salesforce sign outside an office building in New York.

Scott Mlyn | CNBC

Check out the companies that make headlines for trading at noon on Wednesday:

Allbirds — Allbirds shares fell more than 16% after shoe maker losses increased in the third quarter, despite higher earnings from last year. Allbirds was the first listed company to report its quarterly financial results.

Lennar — Following an upgrade to buy from Hold at Goldman Sachs, Lennar’s share rose 3.3%, surpassing other homebuilders. The investment company said Renner’s business strategy should lead to strong growth in 2022.

Vertex Pharmaceuticals — Vertex Share After Biotechnology Companies Announce Positive Results from Research on VX-147 Candidate Drugs in Severe Hereditary Nephropathy and Plan to Advance It to Critical Development Has risen by more than 9%.

Moderna — The pharmaceutical company’s share fell 11.8% after the company appealed and lost a patent decision related to its competitor Arbutus Pharma’s drug delivery technology. Arbutus’ share price soared 44%.

Salesforce — Software giant’s share fell 11.7% against the backdrop of mixed guidance in the fourth quarter, which masked better-than-expected results in the third quarter. Salesforce, along with Marc Benioff, also announced Bret Taylor as the new co-CEO.

ExxonMobil — Exxon shares rose 2% at noon, but today as the company predicted that revenues and cash flow would double from 2019 levels by 2027 while reducing emissions. Finished slightly lower. The company said it expected to spend $ 30 to $ 35 billion a year before the pandemic, while it plans to spend $ 20 to $ 25 billion a year by 2027.

Box — Cloud service company Box saw a 10% surge in shares following its quarterly earnings. Box earned $ 224 million in revenue of 22 cents per share, while Refinitv estimates it was $ 218.5 million in revenue of 21 cents per share.

Ambarella — Semiconductor company stocks surged 14% following higher-than-expected quarterly reports. Amberella recorded a profit of 57 cents per share, 8 cents above Refinitiv’s estimate. Revenue was $ 92.2 million, but the forecast was $ 90.3 million.

Build-A-Bear Workshop — Teddy bear retailers reported record earnings in the third quarter and confirmed that stocks rose nearly 27% after raising guidance for the full year. It also approved a share buyback of up to $ 25 million.

— CNBC’s Hannah Miao and Jesse Pound contributed to the report

Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc.

Source link Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc.

Back to top button